
First German haemophilia B patient receives gene therapy HEMGENIX
CSL Behring marks new era in treatment with milestone reimbursement model The first haemophilia B patient in Germany has been treated with the one-time gene therapy HEMGENIX at the Hemophilia Treatment Center at Hannover Medical School, CSL Behring Germany …